Related references
Note: Only part of the references are listed.The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial
Hadeer Zakaria et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)
Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial
Jose Tarcisio G. Carvalho et al.
PLOS ONE (2017)
Role of Vitamin D in Uremic Vascular Calcification
Yi-Chou Hou et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients
Yueh-Ting Lee et al.
CLINICA CHIMICA ACTA (2016)
Pleiotropic effects of vitamin D in chronic kidney disease
Wen-Chih Liu et al.
CLINICA CHIMICA ACTA (2016)
Vitamin D and cardiovascular disease prevention
Stefan Pilz et al.
NATURE REVIEWS CARDIOLOGY (2016)
Screening for Vitamin D Deficiency: A Systematic Review for the US Preventive Services Task Force
Erin S. LeBlanc et al.
ANNALS OF INTERNAL MEDICINE (2015)
Vascular calcification: from pathophysiology to biomarkers
Severine Evrard et al.
CLINICA CHIMICA ACTA (2015)
Changes of plasma concentration of osteoprotegerin and its association with endothelial dysfunction before and after hypouricemic therapy in patients with hyperuricemia
Hao-hua Wang et al.
MODERN RHEUMATOLOGY (2015)
Biochemical Parameters After Cholecalciferol Repletion in Hemodialysis: Results From the VitaDial Randomized Trial
Annick Massart et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study
Ditte Hansen et al.
BMC NEPHROLOGY (2014)
Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study
Maite Daroux et al.
JOURNAL OF NEPHROLOGY (2013)
Biochemical markers of vascular calcification in elderly hemodialysis patients
Alvaro Osorio et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study
Pierre Delanaye et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Fibroblast Growth Factor 23 is a Predictor of Aortic Artery Calcification in Maintenance Hemodialysis Patients
Zijin Chen et al.
RENAL FAILURE (2013)
Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
Panagiotis Pateinakis et al.
BMC NEPHROLOGY (2013)
Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis
Haimanot Wasse et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease
Michal L. Melamed et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
Peng Hu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk
Nigel D. Toussaint et al.
NEPHROLOGY (2012)
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
L. Desjardins et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials
Praveen Kandula et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
Katherine Wesseling-Perry et al.
KIDNEY INTERNATIONAL (2011)
Serum Osteoprotegerin Is a Predictor of Progression of Atherosclerosis and Coronary Calcification in Hemodialysis Patients
Ilona Kurnatowska et al.
NEPHRON CLINICAL PRACTICE (2011)
Cholecalciferol Supplementation in Hemodialysis Patients: Effects on Mineral Metabolism, Inflammation, and Cardiac Dimension Parameters
Patricia Joao Matias et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Cholecalciferol Supplementation Alters Calcitriol-Responsive Monocyte Proteins and Decreases Inflammatory Cytokines in ESRD
Jason R. Stubbs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Increased fetuin-A levels following treatment with a vitamin D analog
Lucio Manenti et al.
KIDNEY INTERNATIONAL (2010)
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Patricia Joao Matias et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients
Faruk Tokmak et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification
JL Reynolds et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients
K Nitta et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Vascular calcification - Mechanisms and clinical ramifications
M Abedin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Share Paper
